Cargando…

A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma

Recent clinical trials have demonstrated targeting PI3K pathway is a promising strategy for the treatment of blood cancers. To identify novel PI3K inhibitors, we performed a high throughput virtual screen and identified several novel small molecule compounds, including PIK-C98 (C98). The cell-free e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jingyu, Wang, Man, Yu, Yang, Qi, Huixin, Han, Kunkun, Tang, Juan, Zhang, Zubin, Zeng, Yuanying, Cao, Biyin, Qiao, Chunhua, Zhang, Hongjian, Hou, Tingjun, Mao, Xinliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381587/ https://www.ncbi.nlm.nih.gov/pubmed/25474140

Ejemplares similares

Correction: A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma
por: Zhu, Jingyu, et al.
Publicado: (2019)

An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway
por: Xu, Xin, et al.
Publicado: (2016)

SC06, a novel small molecule compound, displays preclinical activity against multiple myeloma by disrupting the mTOR signaling pathway
por: Han, Kunkun, et al.
Publicado: (2015)

Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization
por: Han, Kunkun, et al.
Publicado: (2014)

A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway
por: Zhang, Zubin, et al.
Publicado: (2016)

A virtual screen identified C96 as a novel inhibitor of phosphatidylinositol 3-kinase that displays potent preclinical activity against multiple myeloma in vitro and in vivo
por: Tang, Juan, et al.
Publicado: (2014)

Correction: A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway
por: Zhang, Zubin, et al.
Publicado: (2016)

Anti-bacterial and anti-viral nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf
por: Xu, Yujia, et al.
Publicado: (2020)

Ring finger protein 6 promotes breast cancer cell proliferation by stabilizing estrogen receptor alpha
por: Zeng, Yuanying, et al.
Publicado: (2017)

Clioquinol induces pro-death autophagy in leukemia and myeloma cells by disrupting the mTOR signaling pathway
por: Cao, Biyin, et al.
Publicado: (2014)

Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis
por: Wang, Siyu, et al.
Publicado: (2017)

The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis
por: Xu, Yujia, et al.
Publicado: (2017)

Saponins From Paris forrestii (Takht.) H. Li Display Potent Activity Against Acute Myeloid Leukemia by Suppressing the RNF6/AKT/mTOR Signaling Pathway
por: Lu, Qin, et al.
Publicado: (2018)

Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis
por: Sun, Tong, et al.
Publicado: (2021)

The deubiquitinase USP10 restores PTEN activity and inhibits non–small cell lung cancer cell proliferation
por: He, Yuanming, et al.
Publicado: (2021)

Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemia
por: Zhuang, Haixia, et al.
Publicado: (2022)

Interferon-stimulated gene 15 induces cancer cell death by suppressing the NF-κB signaling pathway
por: Mao, Hongwu, et al.
Publicado: (2016)

The ubiquitin ligase HERC4 suppresses MafA transcriptional activity triggered by GSK3β in myeloma by atypical K63-linked polyubiquitination
por: Zhang, Zubin, et al.
Publicado: (2023)

RiPerC Attenuates Cerebral Ischemia Injury through Regulation of miR-98/PIK3IP1/PI3K/AKT Signaling Pathway
por: Zhang, Dengwen, et al.
Publicado: (2020)

The Natural Pesticide Dihydrorotenone Induces Human Plasma Cell Apoptosis by Triggering Endoplasmic Reticulum Stress and Activating p38 Signaling Pathway
por: Zhang, Jieyu, et al.
Publicado: (2013)

Correction: The Natural Pesticide Dihydrorotenone Induces Human Plasma Cell Apoptosis by Triggering Endoplasmic Reticulum Stress and Activating p38 Signaling Pathway
por: Zhang, Jieyu, et al.
Publicado: (2020)

Lifetime measurement of pi+pi- and piK atoms to test low-energy QCD
por: Nemenov, L
Publicado: (2009)

piK atom: Observation and lifetime measurement with DIRAC
por: Lanaro, A
Publicado: (2001)

Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma
por: Drew, Allison E., et al.
Publicado: (2017)

Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis
por: Jiang, Shuoyi, et al.
Publicado: (2021)

Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer
por: Jeong, Yeong Gyu, et al.
Publicado: (2023)

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
por: Chettab, Kamel, et al.
Publicado: (2023)

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data
por: Zardavas, Dimitrios, et al.
Publicado: (2014)

CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells
por: Schütze, Kerstin, et al.
Publicado: (2018)

Multiplying Preclinical Models for Multiple Myeloma
por: Tesio, Melania
Publicado: (2023)

Targeting BRAF(V600E) with PLX4720 Displays Potent Antimigratory and Anti-invasive Activity in Preclinical Models of Human Thyroid Cancer
por: Nucera, Carmelo, et al.
Publicado: (2011)

HER2-Targeted Antibody–Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget’s Disease Models: In Vivo and Immunohistochemical Analyses
por: Tokuchi, Keiko, et al.
Publicado: (2022)

Design of a surrogate Anticalin protein directed against CD98hc for preclinical studies in mice
por: Deuschle, Friedrich‐Christian, et al.
Publicado: (2020)

Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl–Pyrimidine Moiety
por: Borsari, Chiara, et al.
Publicado: (2019)

98 : derrota pírrica /
Publicado: (2000)

Phage Display Cloning and Characterization of Monoclonal Antibody Genes and Recombinant Fab Fragment against the CD98 Oncoprotein
por: Itoh, Kunihiko, et al.
Publicado: (2001)

Lifetime measurement of pipi and piK atoms to test precise predictions of low-energy QCD
por: Nemenov, L
Publicado: (2009)

Pik3ip1 Modulates Cardiac Hypertrophy by Inhibiting PI3K Pathway
por: Song, Hong Ki, et al.
Publicado: (2015)

ORBIS '98
Publicado: (1998)

WA98
por: Königsmann, K C
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_j4lumje4d8hhi3hj575ch8e2sr